Key Features

  • Under Development, FDA Approval Required.
  • USA National Laboratory Study shows 100% Efficacy in C57BL/6 Mice.
  • Research Paper: An effective CTL peptide vaccine for Ebola Zaire Based on Survivors’ CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design. [PDF] [Publisher Website].
  • Non-human primate study in progress (Winter 2021).

Current Status

  • PRE-CLINICAL FEASIBILITY
  • PRE-PHASE I CLINICAL STUDY
  • PHASE I